A detailed history of Four Tree Island Advisory LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Four Tree Island Advisory LLC holds 59,130 shares of BMY stock, worth $2.77 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
59,130
Previous 59,130 -0.0%
Holding current value
$2.77 Million
Previous $2.74 Billion 2.57%
% of portfolio
1.7%
Previous 1.93%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$44.12 - $59.6 $327,635 - $442,589
-7,426 Reduced 11.16%
59,130 $2.74 Billion
Q1 2025

May 05, 2025

BUY
$53.9 - $63.11 $796,803 - $932,955
14,783 Added 28.55%
66,556 $4.06 Billion
Q4 2024

Jan 28, 2025

BUY
$51.92 - $59.94 $2.69 Million - $3.1 Million
51,773 New
51,773 $2.93 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Four Tree Island Advisory LLC Portfolio

Follow Four Tree Island Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Tree Island Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Tree Island Advisory LLC with notifications on news.